Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ENB-105 by Ennovabio for Inflammatory Bowel Disease: Likelihood of Approval
ENB-105 is under clinical development by Ennovabio and currently in Phase I for Inflammatory Bowel Disease. According to GlobalData, Phase...
ENB-104 by Ennovabio for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
ENB-104 is under clinical development by Ennovabio and currently in Phase I for Peripheral T-Cell Lymphomas (PTCL). According to GlobalData,...
ENB-106 by Ennovabio for Acute Renal Failure (ARF) (Acute Kidney Injury): Likelihood of Approval
ENB-106 is under clinical development by Ennovabio and currently in Phase III for Acute Renal Failure (ARF) (Acute Kidney Injury)....
ENB-106 by Ennovabio for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
ENB-106 is under clinical development by Ennovabio and currently in Phase III for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to GlobalData,...
ENB-104 by Ennovabio for Inflammatory Bowel Disease: Likelihood of Approval
ENB-104 is under clinical development by Ennovabio and currently in Phase I for Inflammatory Bowel Disease. According to GlobalData, Phase...